News & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreNews & Trends - Pharmaceuticals
UCB nabs TGA approval for first dual action anti-seizure therapy
UCB Australia has secured Therapeutic Goods Administration (TGA) approval for the first dual action anti seizure medicine, Fintepla (fenfluramine). The […]
MoreNews & Trends - Pharmaceuticals
AstraZeneca’s SGLT-2 inhibitor PBS listed for patients with type 2 diabetes and high cardiovascular risk
More than 100,000 Australians living with type 2 diabetes and high cardiovascular risk will gain earlier access to AstraZeneca’s SGLT-2 […]
MoreNews & Trends - Pharmaceuticals
‘Expertise, innovation and community’ fuel launch of Heart Health Collective
Cardiovascular disease (CVD) remains the leading cause of death and disease burden in Australia, affecting over 4.2 million people and […]
MoreNews & Trends - Pharmaceuticals
Access to ‘affordable healthcare’ surges in national priorities amid delays to HTA reforms
Access to “quality affordable” healthcare has emerged as the second most important national priority for Australians, just behind the cost […]
MoreNews & Trends - Pharmaceuticals
The urgency of restoring public trust: Pfizer’s Medical Director addresses the essentials in prevention and health reforms
The erosion of public trust in government and medical science emerged as a stark challenge revealed by the year-long COVID-19 […]
MoreNews & Trends - Pharmaceuticals
PBAC and MSAC Chairs voice concerns, threatening more delays to HTA reforms
Sharp concerns from the Chairs of the Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC) have surfaced […]
MoreNews & Trends - Pharmaceuticals
Why is HTA undermining the value of patient preference data in decision-making?
The potential value of patient preference (PP) data in health technology assessment (HTA) is widely acknowledged. Yet, despite growing calls […]
MoreNews & Trends - Pharmaceuticals
PBS listing of Bayer’s endometriosis therapy ends a 30-year wait, marking a milestone in women’s health
Australians living with endometriosis, a chronic and debilitating condition causing severe pain and infertility, now have subsidised access to Bayer’s […]
MoreNews & Trends - Pharmaceuticals
March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions
The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]
MoreRecent Posts in Pharma, MedTech & Biotech
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
December 11, 2024
in News & Trends - Pharmaceuticals
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
December 11, 2024
in News & Trends - MedTech & Diagnostics
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
December 11, 2024
in News & Trends - Pharmaceuticals
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
December 10, 2024
in Communication
Health insurers must refund gouged members’ profits: APHA CEO urges Health Minister to take firm action
December 10, 2024
in News & Trends - MedTech & Diagnostics
MTAA announces new Board Chair and Vice Chairs
December 10, 2024
in News & Trends - MedTech & Diagnostics
UCB nabs TGA approval for first dual action anti-seizure therapy
December 10, 2024
in News & Trends - Pharmaceuticals
Health Minister’s warning to private health insurers: ‘Stop this practice immediately, or I’ll force you to stop’
December 9, 2024
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More